Neurology Book

http://www.fpnotebook.com/

TiagabineAka: Gabitril

Advertisement

  1. Class
    1. Anticonvulsant
  2. Indications: Adjunctive Therapy
    1. Simple Partial Seizure
    2. Complex Partial Seizure
    3. Bipolar Disorder (not FDA approved)
  3. Adverse Effects: Dose related
    1. Sedation
    2. Dizziness
    3. Lethargy
    4. Tremor
    5. Nervousness
  4. Adverse Effects: Other
    1. Nonconvulsive Status Epilepticus
  5. Precautions
    1. Adjust dose in hepatic disease
  6. Dose: Adults and children over age 12
    1. Initial: 4 mg PO qd for first week
    2. Increase by 4-8 mg increments per day weekly
    3. Divide daily dose to bid-qid after first week
    4. Maximum: 56 mg/day divided bid-qid

tiagabine (C0068897)

ConceptsOrganic Chemical (T109) , Pharmacologic Substance (T121)
Englishtiagabine, TIAGABINE PREPARATION
Spanishtiagabina
CreditsDerived from the NIH UMLS (Unified Medical Language System)


Gabitril (C0720560)

ConceptsOrganic Chemical (T109) , Pharmacologic Substance (T121)
EnglishGabitril
CreditsDerived from the NIH UMLS (Unified Medical Language System)



Navigation Tree